-

Parthenon Capital Announces Closing of Parthenon Investors VII

BOSTON--(BUSINESS WIRE)--Parthenon Capital, a leading growth-oriented private equity firm with offices in Boston, San Francisco and Austin, announced its affiliate, Parthenon Investors VII (“Parthenon Fund VII”), held its first and final closing with more than $4.5 billion in commitments. Parthenon Fund VII exceeded its initial fund target of $3.5 billion.

“We appreciate the swift, significant support we received from existing limited partners and are excited to welcome an outstanding group of new investors to the Parthenon family,” said Brian Golson, managing partner and co-chief executive officer. “We feel well positioned for the opportunities ahead.”

Dave Ament, managing partner and co-chief executive officer, added, “We remain excited by the many opportunities to build franchise companies in our target sectors and look forward to deploying our strategy and enhancing our capabilities as a firm in the coming years.”

Ropes & Gray LLP was counsel to Parthenon Fund VII, while Kirkland & Ellis represented Parthenon Capital for all management company documentation. Parthenon did not use a placement agent in the fundraising.

ABOUT PARTHENON CAPITAL
Parthenon Capital is a leading mid-market private equity firm with offices in Boston, San Francisco and Austin. Parthenon utilizes niche industry expertise and a deep execution team to invest in growth companies in service and technology industries. Parthenon seeks to be an active and aligned partner to management, either through recapitalization transactions or by backing new executives. Parthenon has particular expertise in financial and insurance services, healthcare and business services, but seeks any service, technology or delivery business with a strong value proposition and proprietary know-how. www.parthenoncapital.com

Contacts

Molly Fazio Kloos, Parthenon Capital
617-960-4012
mollyk@parthenoncapital.com

Parthenon Capital


Release Versions

Contacts

Molly Fazio Kloos, Parthenon Capital
617-960-4012
mollyk@parthenoncapital.com

More News From Parthenon Capital

Elevate Patient Financial Solutions Announces Strategic Investment from Audax Private Equity and Parthenon Capital

SPRING, Texas--(BUSINESS WIRE)--Elevate Patient Financial Solutions (“Elevate” or the “Company”), a leading provider of front-end eligibility and enrollment and back-end revenue cycle management (“RCM”) technology and services, announced a strategic investment from Audax Private Equity (“Audax”) and Parthenon Capital (“Parthenon”), two private equity firms with a long history of supporting innovative healthcare businesses. The investment will provide Elevate with additional resources and capita...

Parthenon Capital Announces Strategic Growth Investment in Medical Review Institute of America

SALT LAKE CITY--(BUSINESS WIRE)--Medical Review Institute of America (“MRIoA” or the “Company”), a leading provider of outsourced utilization management and clinical review solutions to payers, announced a strategic investment from Parthenon Capital (“Parthenon”), a growth-oriented private equity firm. As part of the transaction, MRIoA management and Summit Partners, an investor in MRIoA since 2017, will both retain significant positions in the business. Financial terms were not disclosed. “We...

Parthenon Capital Sells Institutional Cash Distributors, a Leading Independent, Multi-Fund Investment Platform for Corporate Treasury Professionals, to Tradeweb Markets, Inc.

SAN FRANCISCO--(BUSINESS WIRE)--Parthenon Capital, a leading growth-oriented private equity firm, announced today the signing of a definitive agreement to sell Institutional Cash Distributors, LLC (“ICD”), an institutional investment software and technology provider for corporate treasury organizations trading short-term investments, to Tradeweb Markets, Inc. (NASDAQ: TW). The closing of the transaction is subject to customary conditions and regulatory approvals. Based in Golden, CO, the ICD po...
Back to Newsroom